Miyake Hideaki, Ono Yoshiharu, Park Soo-Jeon, Hara Isao, Eto Hiroshi
Department of Urology, Hyogo Medical Center for Adults, Akashi, Japan.
Int J Urol. 2003 Jul;10(7):383-6. doi: 10.1046/j.1442-2042.2003.00644.x.
The objective of the present study was to analyze the pathological findings of radical prostatectomy specimens diagnosed on single core positive prostate biopsy in eight systematic transrectal ultrasonography (TRUS)-guided biopsies with a Gleason score </= 4.
Between January 1993 and March 2001, 975 patients underwent TRUS-guided prostate biopsy, and 32 patients were diagnosed as having prostate cancer based only on one positive core with a Gleason score </= 4. In this study, 14 of the 32 patients who underwent radical prostatectomy without any neoadjuvant therapies were enrolled, and the pathological findings of their radical prostatectomy specimens were evaluated.
The clinical stage of the 14 patients was T1c in 10 and T2 in four. Cancer was detected in the prostate apex in seven patients, the middle in two, the base of the peripheral zone (PZ) in three, the lateral horn of the PZ in one and the transitional zone (TZ) one. Pathological stage of the 14 patients was pT2a in four, pT2b in six, pT3a in three and pT3b one. Gleason score of the radical prostatectomy specimens in 11 patients was also </= 4. Of the 10 patients diagnosed with cT1c, extraprostatic disease was found in only one radical prostatectomy specimen. All three patients whose cancer was detected from the base of the PZ showed pT3 disease. During the median follow-up period of 47.5 months, all patients were alive with no evidence of disease.
The prognosis of patients who were diagnosed with one core positive prostate biopsy with a Gleason score </= 4 is generally favorable; however, advanced disease tended to be observed in patients who were diagnosed with cT2a and/or whose cancer was detected from the base of PZ.
本研究的目的是分析在8次系统经直肠超声(TRUS)引导下活检中,Gleason评分≤4的单核心阳性前列腺活检诊断的根治性前列腺切除术标本的病理结果。
1993年1月至2001年3月期间,975例患者接受了TRUS引导下的前列腺活检,32例患者仅基于一个Gleason评分≤4的阳性核心被诊断为前列腺癌。在本研究中,32例接受了根治性前列腺切除术且未进行任何新辅助治疗的患者中有14例被纳入,其根治性前列腺切除术标本的病理结果得到评估。
14例患者的临床分期为10例T1c和4例T2。7例患者在前列腺尖部发现癌症,2例在中部,3例在外周带(PZ)底部,1例在PZ侧角,1例在移行带(TZ)。14例患者的病理分期为4例pT2a,6例pT2b,3例pT3a和1例pT3b。11例根治性前列腺切除术标本的Gleason评分也≤4。在10例诊断为cT1c的患者中,仅1例根治性前列腺切除术标本发现前列腺外疾病。从PZ底部检测到癌症的所有3例患者均显示pT3疾病。在中位随访期47.5个月期间,所有患者均存活且无疾病证据。
Gleason评分≤4的单核心阳性前列腺活检诊断的患者预后通常良好;然而,在诊断为cT2a和/或其癌症从PZ底部检测到的患者中倾向于观察到晚期疾病。